Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

BACKGROUND: Four previously published randomised clinical trials have shown that tamoxifen can reduce the risk of breast cancer in healthy women at increased risk of breast cancer in the first 10 years of follow-up. We report the long-term follow-up of the IBIS-I trial, in which the participants and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzick, Jack, Sestak, Ivana, Cawthorn, Simon, Hamed, Hisham, Holli, Kaija, Howell, Anthony, Forbes, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772450/
https://www.ncbi.nlm.nih.gov/pubmed/25497694
http://dx.doi.org/10.1016/S1470-2045(14)71171-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772450/
https://www.ncbi.nlm.nih.gov/pubmed/25497694
http://dx.doi.org/10.1016/S1470-2045(14)71171-4

Ejemplares similares